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Abstract
Genetically engineered pigs serve as excellent biomedical and agricultural models. To
date, the most reliable way to generate genetically engineered pigs is via somatic cell
nuclear transfer (SCNT), however, the efficiency of cloning in pigs is low (1–3%).
Somatic cells such as fibroblasts frequently used in nuclear transfer utilize the
tricarboxylic acid cycle and mitochondrial oxidative phosphorylation for efficient
energy production. The metabolism of somatic cells contrasts with cells within the
early embryo, which predominately use glycolysis. We hypothesized that fibroblast
cells could become blastomere‐like if mitochondrial oxidative phosphorylation was
inhibited by hypoxia and that this would result in improved in vitro embryonic
development after SCNT. In a previous study, we demonstrated that fibroblasts
cultured under hypoxic conditions had changes in gene expression consistent with
increased glycolytic/gluconeogenic metabolism. The goal of this pilot study was to
determine if subsequent in vitro embryo development is impacted by cloning porcine
embryonic fibroblasts cultured in hypoxia. Here we demonstrate that in vitro
measures such as early cleavage, blastocyst development, and blastocyst cell number
are improved (4.4%, 5.5%, and 17.6 cells, respectively) when donor cells are cultured
in hypoxia before nuclear transfer. Survival probability was increased in clones from
hypoxic cultured donors compared to controls (8.5 vs. 4.0 ± 0.2). These results
suggest that the clones from donor cells cultured in hypoxia are more developmen-
tally competent and this may be due to improved nuclear reprogramming during
somatic cell nuclear transfer.
K E YWORD S
blastocyst, cell culture, cloning, fetal development, hypoxia, litter size, metabolism, nuclear
transfer, porcine/pig, pregnancy, reprogramming, somatic cell nuclear transfer
© 2019 The Authors Molecular Reproduction and Development Published by Wiley Periodicals, Inc.
Mol Reprod Dev. 2019;86:558-565.558 | wileyonlinelibrary.com/journal/mrd
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
1 | INTRODUCTION
For two decades, since the creation of the cloned first lamb using a
somatic cell donor, the scientific community has strived to improve the
efficiency of somatic cell nuclear transfer (SCNT) in mammals (Camp-
bell, McWhir, Ritchie, & Wilmut, 1996; Gábor, 2018). Notably,
numerous live animals from 23 species have been successfully produced
by SCNT due to an amalgamation of efforts from several dedicated
researchers discovering new strategies (reviewed in Loi, Iuso, Czernik, &
Ogura, 2016). Therefore efficiency has improved over time and
breakthroughs are still occurring, where even the most challenging
species are proving to be clonable (Liu et al., 2018). While other
emerging techniques are improving, such as zygote injection of CRISPR/
Cas9, SCNT is still one of the most efficient ways to reliably create
genetically engineered animals. Despite the successful induction
protocols for ESC and iPSC in rats (Liao et al., 2009) and mice (Bryja,
Bonilla, & Arenas, 2006), creating reliable protocols has proven to be
more challenging in the larger domestic species. A major hurdle for cow
and pig iPSCs is that both 1) require continued expression of the
introduced transgenes to maintain some degree of pluripotency, 2) have
limited passage life, and 3) are not able to form teratomas in
immunodeficient mice (reviewed in Ezashi, Yuan, & Roberts, 2016).
Due to these challenges, SCNT is still popular in swine.
Gene‐edited and/or transgenic (GET) pigs serve as excellent models
to study disease progression and develop treatments for human genetic
disorders. The pig, in particular, conveys great similarity to humans in
their anatomy, physiology, and genomics, therefore, allowing them to
exhibit symptoms of human pathologies more accurately and reliably
than other animal models (reviewed in Fan & Lai, 2013; Prather, Lorson,
Ross, Whyte, & Walters, 2013; Walters et al., 2012). For several
reasons, GET pigs are the most likely donor option for future
xenotransplantation of organs; therefore great efforts have been
underway to make this possibility a reality (Bottino et al., 2014; Ekser,
Rigotti, Gridelli, & Cooper, 2009; Klymiuk, Aigner, Brem, & Wolf, 2010;
Lai et al., 2002; Lavitrano et al., 2002; Lutz et al., 2013; Mohiuddin et al.,
2014; L. Yang et al., 2015). Due to the usefulness of GET pigs in both
biomedicine and agriculture, there is a growing need for the creation of
new or improved upon models, which at this time, is still predominately
achieved via SCNT. Currently, the efficiency of SCNT in pigs is
approximately 1–3% (Whitworth & Prather, 2010). This percentage
varies slightly depending on if investigators calculate success rate based
on total embryos reconstructed, total embryos transferred, or
pregnancy rate of surrogates to which embryos were transferred.
Nevertheless, this rate is low and there is a substantial need for
improvement. When blastomeres are used as donor cells for SCNT the
rate of success is significantly improved (Mitalipov, Yeoman, Nusser, &
Wolf, 2002). Therefore we speculated that if somatic cells could be
induced to be more blastomere‐like, the cloning efficiency may be
greatly improved.
There is growing evidence that cellular reprogramming is
facilitated in part by upregulation of glycolysis (Folmes et al., 2011;
Kondoh et al., 2005; Moussaieff et al., 2015; Zhu et al., 2010). In light
of this, we reasoned promoting a highly glycolytic metabolism could
facilitate nuclear reprogramming. Somatic cells predominately use
mitochondrial oxidative phosphorylation and the citric acid cycle for
the production of energy whereas the metabolism of preimplantation
embryos is evidenced to be more glycolytic and Warburg effect‐like
in nature (Krisher & Prather, 2012). We hypothesized that if donor
fibroblasts were cultured under hypoxic conditions, it would elicit the
higher glycolytic activity thereby promoting metabolism exhibited in
the blastomeres of early embryos. We speculated this would aid in
the facilitation of nuclear reprogramming and improve cloning
efficiency. In this study, we investigated if restricting oxygen from
donor fibroblasts during cell culture would improve measures of in
vitro developmental quality in reconstructed pig embryos and
improve survival through early gestation.
2 | RESULTS
Fusion of reconstructed embryos was not significantly different
(p = 0.10) between hypoxic (HYP) and control (CON) cultured
fibroblast donors and was not different amongst cell lines
(p = 0.44). While the total proportion of embryos cleaved was not
different between donor fibroblast oxygen culture treatments
(p = 0.75), HYP reconstructed clones had a higher (p = 0.03) propor-
tion cleave earlier (within the first 24 hr) compared to control in both
experiments (Table 1). Likewise, a higher proportion of CON embryos
TABLE 1 In vitro development and gestational Day 35 survival of
clones from donor cells cultured in hypoxia or as controls
Treatmenta
Hypoxia Control
Standard
error p‐Value
Fusionb (%) 85.2 82.8 1.0 0.10
Early cleavagec (%) 61.6 57.2 1.4 0.03*
Later cleavaged (%) 15.5 18.6 1.1 0.04*
Total cleavagee (%) 77.1 76.1 1.1 0.53
Total blastocyst
developmentf (%)
36.4 30.9 1.3 <0.01*
Blastocyst cell numberg 52.7 35.1 3.0 <0.0001*
Survival
probabilityh (%)
8.5 4.0 0.2 0.03*
aIn vitro development measures of somatic cell nuclear transfer (SCNT)
embryos from donor cells cultured in hypoxia (hypoxic; 2 days at
5% oxygen, 1 day at 2.5% oxygen, 4 days at 1.25% oxygen) or as controls
(control; 5% oxygen 7 days).
bPercentage of embryos successfully fused from total reconstructed
embryos of SCNT embryos.
cPercentage of embryos successfully cleaved within 24 hr from SCNT.
dPercentage of embryos successfully cleaved within 44 hr from SCNT
excluding those formed by 24 hr.
eTotal percentage of embryos successfully cleaved after SCNT.
fPercentage of embryos successfully forming blastocyst stage embryos
within 7 days from SCNT.
gNumber of cells in blastocyst stage SCNT embryos.
hNumber of favorable outcomes (viable fetuses) from total events (all
embryos transferred) expressed as a percentage (multiplied by 100).
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cleaved later (at least by 44 hr) than HYP (p = 0.04; Table 1). Total,
early, and late cleavage was not significantly different amongst cell
lines which were used in embryo transfer experiments (p ≥ 0.06)
however some of these measures were lower in the cell line used for
preliminary in vitro experiments (p < 0.01).
Blastocyst production was improved when embryos were created
from HYP donors (p< 0.01; Table 1 and Figure 1). Furthermore,
blastocysts from HYP donors contained more nuclei than CON
(p < 0.0001; See Table 1 and Figure 1). Blastocyst production was lower
in the homozygous knockout (KO) cell line (p ≤ 0.01; 24%) and similar
amongst the other cell lines used (p≥ 0.15; average 33%; SE = 2%). In
utero, the homozygous KO line had lower survival than the hetero-
zygous KO line (p =0.01; 0.3 ± 2.9 vs. 9.4 ± 1.6%) but not different from
the Ossabaw line (p = 0.49; 4.27; Figure 2 provides examples of Day 35
fetal genotyping for sialoadhesin [SIGLEC1] editing). Ossabaw and the
heterozygous KO line did not have significantly different survival in
utero (p= 0.05). From 446 embryos transferred into 12 surrogates,
6 surrogates became pregnant carrying 20 HYP and 9 CON fetuses
(Table 2). Fetuses collected were similarly sized amongst treatments
(p = 0.17; CON=3.16 ± 0.14 cm; HYP=2.93 ± 0.09 cm) and cell lines
(p = 0.06; OSS = 3.30 ± 0.16 cm; heterozygous KO=2.90 ± 0.08 cm;
homozygous KO=3.5 ± 0.39 cm). Survival probability was increased
when clones were from HYP versus CON donors (p = 0.025; Table 1).
This corresponded to a 2.5‐fold increase in overall system efficiency
(blastocyst development rate * fetal survival rate) in HYP clones versus
CON (3.0% vs. 1.2% efficiency).
3 | DISCUSSION
In an effort to improve cloning, several studies have attempted to
elucidate what constitutes the ‘ideal donor cell.’ These studies
include investigations of serum starvation and cell cycle regulation,
type of cell, age of animal from which cells were extracted, age of
cells themselves (or passage number), epigenetic reprogramming,
degree of pluripotency, and antioxidant treatment of cells (Bonk
et al., 2007; Campbell et al., 1996; Chen et al., 2015; Dominko et al.,
1999; Heyman et al., 2002; Iager et al., 2008; Kato, Tani, & Tsunoda,
2000; Mitalipov et al., 2002; Oback & Wells, 2007; Powell et al.,
2004; Tani, Kato, & Tsunoda, 2001; Wakayama & Yanagimachi, 2001;
Wells et al., 2003; Whitworth, Zhao, Spate, Li, & Prather, 2011;
Wilmut et al., 2002; X. Yang et al., 2012). Proper nuclear remodeling
and epigenetic reprogramming of donor cells is revered to be the key
to improving SCNT and is thoroughly under examination (reviewed in
Armstrong, Lako, Dean, & Stojkovic, 2006; Niemann, Tian, King, &
Lee, 2008; Whitworth & Prather, 2010). Improper nuclear repro-
gramming has also been attributed to the developmental defects
which are sometimes observed in clones; the genome of somatic cells
must be reset to express genes consistent with appropriate
progression of embryonic development (reviewed in Armstrong
et al., 2006). In accordance with this, when blastomeres are used
as donor cells for SCNT the rate of success was improved (Mitalipov
et al., 2002).
We hypothesized that if porcine fetal fibroblasts (the most
common cell type used for cloning of pigs) were cultured under
hypoxic conditions the metabolism of the donor cells would
become more blastomere‐like and thus it might improve repro-
gramming and subsequent cloning efficiency. Therefore we
designed these experiments to test our hypothesis and see if this
mechanism (hypoxic culture) would be effective and worth
pursuing further. It was desirable that this ‘reprogramming’
induction be through a simple mechanism that could be applied
to any cell line, such as altering the metabolism during culture via
hypoxia. Previously our laboratory reported that oxygen restric-
tion in porcine fetal fibroblasts (the same line used in in vitro
experiments in the current study) induced expression of hexoki-
nases 1 and 2, glucose‐6‐phosphate isomerase, glyceraldehyde‐3‐
phosphate dehydrogenase, triose phosphate isomerase 1, aldolase,
fructose‐bisphosphate C, and phosphoglycerate kinase; all enzymes
involved in glycolysis (Mordhorst, Murphy, Ross, et al., 2018). In
addition, expression of pyruvate dehydrogenase kinase 1 was also
induced, this kinase is evidenced to be a key player in thwarting
the entrance of pyruvate into the TCA cycle thereby effectively
decreasing mitochondrial oxidative phosphorylation (Papandreou,
Cairns, Fontana, Lim, & Denko, 2006). Hypoxia treatment results in
metabolism being shifted to become more blastomere‐like (Mord-
horst, Murphy, Ross, et al., 2018; Redel et al., 2012).
In this study, we demonstrate that measures of in vitro
development were improved when fibroblasts cultured in hypoxia
were used as donors for SCNT. Clones from HYP fibroblasts
consistently cleaved earlier and produced more blastocysts with
higher cell numbers (Table 1; Figures 1,2) regardless of the fibroblast
line used for cloning. Early cleavage is a predictor of developmental
F IGURE 1 Representative images of developmental Day 7
somatic cell nuclear transfer embryos from donor cells cultured in
hypoxia (HYP; 2 days at 5% oxygen, 1 day at 2.5% oxygen, 4 days at
1.2% oxygen) or as controls (CON; 5% oxygen 7 days).
(a) 4× magnification of SCNT embryo groups separated out after
having cleaved early inside 4‐well plates during culture derived from
hypoxic and control cultured donor cells. (b) 20× magnification of
single SCNT blastocysts stained with Hoechst 33342 derived from
hypoxic and control cultured donor cells in the process of hatching
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competence and embryo quality (Cruz et al., 2012; Isom,
Whitworth, & Prather, 2012; Kaith et al., 2015). Additionally, early
cleaving embryos have better rates of pregnancy (Lundin, Bergh, &
Hardarson, 2001).
The improvement in blastocyst production from HYP donors is
modest (5.5%) however this translated to a 1.5‐fold increase in cell
number and 2.1‐fold increase in the probability of survival (fetuses
attained). Overall these changes lead to a 2.5‐fold increase in system
efficiency (blastocyst development rate * fetal survival rate). In this
study, our Day 35 pregnancy rate was 50% (6 of 12 surrogate gilts
became pregnant) which is higher than previous experiments in our
laboratory involving the same personnel (41.6% and 28.6%;
Mordhorst, Murphy, Schauflinger, et al., 2018) through the average
number of fetuses per litter was higher compared to the current
study (5.9 vs. 4.8 fetuses/litter). One limitation of this study is that at
the present time, no piglets have been delivered to term using
hypoxic donors. We did choose to retrieve fetuses at 35 days of
gestation based on research from others indicating that 30% of
conceptus loss occurs in gestation Days 10–30 in pigs (Wessels,
Linton, Croy, & Tayade, 2007).
There were cloning differences between fibroblasts derived from
the same fetal cell line based on whether they were heterozygous or
homozygous Sialoadhesin knockouts (SIGLEC1 KO). The homozygous
SIGLEC1 KO line produced few Day 5 blastocysts, limiting the
number of embryos we could equally transfer from each treatment.
Of the two replicates, two of the four gilts became pregnant and
whereas they were not transferred on the same day, between the
two gilts all combinations of the homozygous and heterozygous KO
lines and donor treatments were represented. Due to the decreased
blastocyst production however we decided to use a different cell line
(Ossabaw) in combination with the SIGLEC1 heterozygous KO line, a
line proven to be ‘clonable’ and yield live animals which has been
used for editing genes by the National Swine Research and Resource
Center (RRID NSRRC:0008; https://nsrrc.missouri.edu/). According
to another study from Kuhholzer, Hawley, Lai, Kolber‐Simonds, and
Prather, (2001) clonal transgenic lines derived from the same pig
fetus had different efficiencies of fusion, but also developed to the
morula and blastocyst stages. One possibility is complications during
embryonic development due to the gene‐altered; however, in our
experience, these SIGLEC1 KO pigs have normal gestational survival
that would indicate the gene modification would not be a hindrance.
As this study was exploratory, additional studies in the field are
needed. Our results indicate that using HYP donors improves cloning
efficiency across different fetal fibroblast cell lines. Given the
promising early results within our laboratory, research is warranted
to investigate whether these results are replicable in other
laboratories for other porcine cell line sources as well as in other
species to determine if nuclear reprogramming is occurring. Further
exploration is necessary to pinpoint effective duration of hypoxic
culture and whether stepwise decreases in oxygen concentration are
necessary. In this study, we used a hypoxic culture method which we
knew to be effective in inducing a hypoxic cellular phenotype and
changes in gene expression (Mordhorst, Murphy, Ross, et al., 2018).
In the present study, we did not note any differences in blastocyst
development or Day 35 pregnancy rates between the use of hypoxic
atmosphere incubators or hypoxic chambers. We switched to hypoxic
chambers due to the feasibility of use as well as cost. One limitation
is that we did not have a system to monitor how much oxygen was in
F IGURE 2 Examples of Day 35 fetal genotyping using PCR
amplification to detect editing of sialoadhesin (SIGLEC1/ SN/ CD169).
Donor cell lines used in early gestation survival experiments were
homozygous or heterozygous SIGLEC1 knockouts or had no editing
(wild type). (a) Example of litter from heterozygous knockout and
wild type cell lines used in somatic cell nuclear transfer. Corresponds
to the litter in the last row of Table 2. (b) Example of litter from
heterozygous and homozygous knockout cell lines used in somatic
cell nuclear transfer. Corresponds to the litter in the first row of
Table 2. PCR: polymerase chain reaction
TABLE 2 Gestational Day 35 fetal retrievals from somatic cell nuclear transfer of hypoxia and control culture treated fibroblasts
Gilt recipient
cycle day
Number of embryos
transferred
Developmental day
of blastocysts Total litter size
Number of
controla fetuses
Number of hypoxiab
fetuses
4 40 5 4 3 1
3 32 5 6c 0 6
5 36 6 5d 1 4
4 40 6 8 2 6
4 40 6 3 0 3
4 36 6 3d 3 0
aFetal fibroblasts used in somatic cell nuclear transfer (SCNT) were cultured in 5% oxygen for 7 days.
bFetal fibroblasts used in SCNT were cultured in hypoxia: 2 days at 5% oxygen, 1 day at 2.5% oxygen, 4 days at 1.25% oxygen.
cUterus also contained two regressed fetuses: one hypoxia and one control.
dUterus also contained two regressed fetuses: three hypoxia and two control.
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chambers after gassing, whereas we could monitor oxygen in real
time with the incubator system. It is possible using the hypoxia
chambers that oxygen could go below 1.2%, but using that apparatus
we could not regularly monitor oxygen content with our current
instrument. However, the consumption of oxygen by two T25 flasks
would presumably not be enough to notably further deplete the
chamber’s oxygen content.
Elucidation of molecular mechanisms as to how hypoxic culture is
able to enhance SCNT would offer insight to cellular metabolic
reprogramming and could shed light on other means to be pursued in
achieving improved cloning efficiencies in the future. To our
knowledge, this is one of the first times cloning efficiency of pigs
has reached this rate aside from a study by Walker et al., where
efficiency was reported as 5.5% (28 piglets/511 SCNT embryos
transferred). In this study, in similar terms, of the 223 embryos from
HYP donors, there were 20 fetuses (~9%); the caveat being future
studies must be conducted which carry HYP clones to term to
ascertain this rate of efficiency holds true. However, at the present,
we thought that these results were novel and worth reporting to the
scientific community to open further exploration into mechanisms
and effectiveness of hypoxic culture on donor cells. From these
experiments, we propose that the clones from donor cells cultured in
hypoxia may be developmentally competent and this may be due to
improved nuclear reprogramming during somatic cell nuclear
transfer. Implications of our results may be a method for improved
efficiency for cloning of pigs.
4 | MATERIALS AND METHODS
Chemicals and materials were purchased from Sigma‐Aldrich,
St. Louis, MO unless otherwise specified.
4.1 | Animal care and compliance with ethical
standards
All procedures performed in studies involving animals were approved
and conducted in accordance with the ethical standards of the
University of Missouri Institutional Animal Care and Use Committee
at the University of Missouri in Columbia, Missouri. This study does
not contain any experiments with human participants.
4.2 | Fetal‐derived fibroblast cell culture
Porcine fetal fibroblast cell lines collected from dorsal regions (fetal
shoulders to the rump/tail head) used in the study were established from
d 35 pregnancies and utilized in previous experiments in our laboratory
(Mordhorst, Murphy, Schauflinger, et al., 2018; Prather, Rowland et al.,
2013). A cryogenic vial of fibroblasts (0.5ml aliquots; ~1.5 million/ml in
media containing 90% fetal bovine serum (FBS) and 10% dimethyl
sulfoxide) was defrosted from liquid nitrogen storage for every replicate
in the experiment. Cells were thawed and cultured in Dulbecco’s
modified Eagle’s medium (1 g/L glucose with phenol red) supplemented
with 15% FBS (Corning, Corning, NY) for seven days in T25 flasks
(Corning). Cells were either treated as controls (CON) cultured in
5% oxygen for the duration of 7 days or cultured in step‐wise decreasing
concentrations of oxygen (HYP) where for 2 days they were maintained
at 5% oxygen, on the third day cultured at 2.5% oxygen, and from the
fourth to the seventh days cultured at 1.2% oxygen. Hypoxic culture
conditions were achieved one of two ways; either via increased nitrogen
gas concentration in a standard mixed gas incubator or by using
purchased preanalyzed mixed gas cylinders to fill humidified modular
incubator chambers, which were placed in incubators.
When whole incubators were used (three initial in vitro
experiment replicates and two replicates of embryo transfer
experiments), a system of four nitrogen tanks connected by one
gas line was assembled to ensure adequate nitrogen gas was
available to incubators. The regulators of nitrogen tanks were set
to sequentially empty the tanks one by one as culture experiments
required a large quantity of nitrogen gas, and at least one of the
tanks had to be exchanged for a full tank daily. During this, oxygen
concentration of incubators was regularly monitored by a handheld
gas monitor (model: InControl 1050; Labotect Labor‐Technik‐
Göttingen GmbH; Göttingen, Germany) which was professionally
tested by Utility Lab Services (part of Thermo‐Fisher Scientific;
Waltham, MA) and proved to have an error of ±0.05% oxygen.
Therefore the low oxygen treatment may have been as high as 1.25%
or as low as 1.15% oxygen. Incubators were maintained at 38.5°C
with a humidified atmosphere of 5.5% carbon dioxide during
experiments.
In experiments where the modular incubator chamber (model
MIC‐101; Billups‐Rothernberg, Inc.; Del Mar, CA) was used (four
replicates of embryo transfer experiments), petri dishes of sterile
water were placed in the bottom of the chamber below the grate to
provide humidity. Vented cell culture flasks were placed inside
chambers, which were then sealed and flooded with mixed gas for
several minutes to displace gas within and achieve hypoxic
conditions. Afterward, air ports were sealed and chambers were
placed in the standard incubators with controls.
Cells from all treatments were plated at the same initial densities
between treatments and either passaged on Day 5 of growth and
plated at the same density (if needed) or had gas‐equilibrated media
changed and allowed to grow 7 days consecutively. Passaging was
done quickly, and dissociation reagents were kept cold in an effort to
decrease the metabolism of cells and prevent the metabolism of
oxygen as much as possible. Media that cells were plated in had been
equilibrated to desired oxygen concentrations by incubating media in
the incubators in petri dishes or within modular incubator chambers
for an hour or more. At passaging, flasks were briefly rinsed with
phosphate buffered saline (PBS) + 0.01M ethylenediaminetetraacetic
acid, and fibroblast cells were dissociated from flasks by brief
incubation (37°C) with 1× TrypLE Express (Gibco, Invitrogen
purchased from Thermo Fisher Scientific, Waltham, MA). Fibroblasts
were pelleted (5min at 500g) and either diluted and replated (Day 5)
or approximately 2,000 cells/treatment were collected and placed in
droplets to be used for selection during SCNT (Day 7).
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4.3 | Somatic cell nuclear transfer and embryo
culture
Methods for SCNT were previously reported by (Mordhorst, Murphy,
Schauflinger, et al., 2018). Sow‐derived oocytes were purchased from
DeSoto Biosciences (Seymour, TN) and shipped overnight in
maturation medium (90% M199 and 10% follicular fluid supplemen-
ted with 0.57mM cysteine, 5 μg/ml insulin, 10 ng/ml epidermal
growth factor, 5 μg/ml LH and FSH). After maturation (40–42 hr),
cumulus cells were removed by gentle vortexing in the presence of
0.1% hyaluronidase. The average percentage of oocyte maturation
across replicates in experiments was 72.9% (standard deviation of
3.1%). Oocytes were selected for enucleation based on the presence
of a polar body and uniform cytoplasm. Oocytes were placed in a
manipulation medium (Lai & Prather, 2003) supplemented with
7.0 µg/ml cytochalasin B during oocyte manipulation. In all experi-
ments, SCNT was performed by two technicians and each treatment
was split evenly amongst the technicians. Order of treatment in
which SCNT was performed first was selected randomly. A hand‐
tooled thin glass capillary was used to remove the polar body along
with a portion of the adjacent cytoplasm (presumably containing the
metaphase II plate) and a donor cell was placed in the perivitelline
space.
Afterward, reconstructed embryos were fused in fusion medium
(0.3M mannitol, 0.1 mM CaCl2, 0.1 mM MgCl2, 0.5 mM HEPES
buffer, pH 7.2) by two DC pulses (1‐s interval) at 1.2 kV/cm for
30 µsec using a BTX Electro Cell Manipulator (Harvard Apparatus,
Holliston, MA). After electric pulse fusion, fused embryos were also
chemically activated with 200 µM thimerosal (in 1× PVA‐TL Hepes)
for 10min in the dark and 8mM dithiothreitol (in 1× PVA‐TL Hepes)
for 30min (Machaty, Wang, Day, & Prather, 1997). Embryos were
then incubated in MU1 (Redel, Tessanne, Spate, Murphy, & Prather,
2015) with a histone deacetylase inhibitor 0.5 µM Scriptaid, for
14–16 hr in a 5% carbon dioxide (atmospheric oxygen) incubator
(Whitworth, Zhao, Spate, Li, & Prather, 2011; Zhao et al., 2009). The
next day, the SCNT embryos were moved into new MU1 culture
media (without scriptaid) and placed in a low (5%) oxygen incubator
with 5% carbon dioxide. During culture, embryos were inspected for
the timing of cleavage (early: 24 hrs postactivation; late: at least by
44 hr) and blastocyst formation. Blastocyst stage SCNT embryos
were fixed with 4% paraformaldehyde (16% paraformaldehyde
diluted to 4% using 1× PVA‐TL Hepes) and stained with Hoechst
33342 on Day 7 of development for quantification of cell number in
the first experiment (three replicates).
In vitro development data were compiled from two experiments:
Experiment 1 consisted of vitro development only; in Experiment 2 in
vitro development data was collected from the embryos transferred
to surrogates. Therefore between the experiments, there were nine
biological replicates and 2,525 oocytes used in SCNT to investigate
whether clones from oxygen restricted donor cells had improved in
vitro development. In both experiments gestational Day 35 fetal
fibroblasts were used, however different cell lines were used. In
Experiment 1 a single cell line was used in SCNT (BRM3P1;
Mordhorst, Murphy, Ross, et al., 2018). In embryo transfer experi-
ments, cell lines proven to produce live offspring were used to
distinguish (via genotyping; Figure 2) which donor cell treatments
survived in utero. Heterozygous or homozygous deletions of
sialoadhesin (SIGLEC1/SN/CD169; Prather, Rowland, et al., 2013) or
WT fibroblasts (a proven Ossabaw fetal fibroblast line, RRID
NSRRC:0008) were cultured under both oxygen treatments and
used as donor fibroblasts for SCNT. The homozygous cell line did not
produce blastocysts well, which limited the number of embryos that
could be transferred equally to surrogates. Due to this, we began
using the WT fibroblast line because previous use had evidenced that
it produced blastocysts well for various edits by other researchers.
4.4 | Embryo transfer
Blastocyst‐stage embryos (N = 16–20 per SCNT fibroblast donor
culture treatment) were surgically transferred into the oviductal
ampullary‐isthmic junction of surrogate gilt recipients (3–5 days
postobserved estrus). Surgical embryo transfer technique was
conducted as previously established within our laboratory (Lai &
Prather, 2003; Mordhorst, Murphy, Schauflinger, et al., 2018). For
embryo transfer experiments, two surrogate gilts were used in each
replicate (six replicates; 12 gilts) in a complete‐block type fashion
where between the gilts each cell line (two of the three different lines
utilized) and donor cell culture treatment (hypoxia and control) were
used. Two ‘sets’ of gilts became pregnant as well as two single gilts
from other replicate sets became pregnant.
4.5 | Fetal collection and genotyping
Surrogates were humanely euthanized via ear vein infusion of
Euthasol (Virbac AH, Inc; Fort Worth, TX) at 35 of embryonic
development. The reproductive tract was excised from the cervix to
ovaries and opened along the entire length of uterine horns for fetal
collection. Tissue was excised from fetuses and washed in 1× PBS
then frozen until DNA extraction and genotyping. To establish which
donor cell treatment survived better in utero, fetuses were
genotyped (Figure 2) via polymerase chain reaction amplification
for the presence of SIGLEC1 alleles using the same primers and
procedure used in Prather, Rowland et al., (2013). When bands were
not clearly obvious, DNA was extracted from frozen samples again
and sent for sequencing verification at the University of Missouri
core facility.
4.6 | Statistical analysis
For in vitro developmental measures, nine replicates (three in vitro
cultured only and six used for embryo transfer; 2,525 total oocytes)
were used in analyses. Three replicates of the same donor cell line
were used to compare cell number within blastocysts for donor cell
oxygen culture treatments (112 total blastocysts). Embryo transfer
data consisted of 446 total blastocysts transferred into 12 surrogates
(6 replicates of surrogate pairs). Data distributions and Shapiro–Wilk
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test of normality values were generated using the Univariate
procedure of SAS (SAS, Cary, NC); log or square root transformations
were made before statistical analysis where necessary to meet
assumptions for analyses. All data were analyzed using a MIXED
procedure in SAS for main effects of donor cell treatment and cell
line; interactions were assessed however this effect was removed
from analyses when found to be insignificant. For embryo transfer
data, blastocysts transferred were nested within surrogate gilt and a
random effect of replicate was used (mainly because it corresponds
to the time/season differences for this study duration). Survival
probability was considered the number of favorable outcomes (viable
fetuses) from the total (embryos transferred). Analyzed variables
were considered statistically different if the p < 0.05.
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